IAM is Paris-bound for biggest IPBC Europe ever
Saturday Opinion: IAM editor Rachel Mountain reflects on what is coming up next week in the City of Lights
Saturday Opinion: IAM editor Rachel Mountain reflects on what is coming up next week in the City of Lights
In an exclusive interview, IP head Van Nguy reveals her rubric for building a foundational portfolio on emerging tech including a mix of patents, trade secrets and trade dress
Mary Guzman of Crown Jewel Insurance speaks to IAM about the burgeoning trade secrets service sector
Dispute's over Genentech's trastuzumab have helped write the patent playbook for innovators and imitators in the biologics space
07 June 2022
The legislative projects covered in the Plan are categorised either as Category I or Category II. It is essential that Category I projects are submitted for compliance checks and internal scrutiny by the deadline to prevent them being demoted to Category II.
01 June 2022
During the two-day IAM Connect AI IP event this week, in-house IP heads from AI companies and AI-focused attorneys revealed their methods of protecting AI assets
20 May 2022
If historical trends repeat, then Appian’s nuclear verdict against rival Pegasystems could lead litigation financiers to seek out more chances to fund trade secrets cases
18 May 2022
Seungho Ahn and another ex-Samsung lawyer, who are advising an NPE campaign against their former employer, say any dispute over trade secrets belongs in a Korean court, not a Texan one
17 May 2022
US International Trade Commission launches most recent investigation into Botox-style product.
16 May 2022
Major companies must now figure out how to maintain compliance with the new measures in IP and other areas
13 May 2022
Data from Docket Navigator shows the venues for trade secrets, trademark and copyright litigation in the US, areas in which the Los Angeles-based US District Court dominates
09 May 2022
Law firm Williams & Connolly is the target of US discovery requests in latest twist to German patent and trade secrets proceedings
09 May 2022
Rights owners have enjoyed success in recent life sciences know-how misappropriation disputes
06 May 2022
Unlock unlimited access to all IAM content